As I responded to Mr. Storseth, of the 12, we compared the U.S. formulation with the Canadian formulation and found that in four of them there were chemical differences that caused a difference in how human health or environmental risk would be affected. So four of the 12 were eliminated for that reason. On two of the 12 that were found to be equivalent, the registrant brought up the fact that they had patents protecting those products. We excluded them, and then we were down to six.
On January 29th, 2008. See this statement in context.